Abstract: The invention relates to preparation comprising at least one omega-3 or omega-6 fatty acid component selected from eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha linolenic acid, stearidonic acid, eicosatetraenoic acid, docosapentaenoic acid, linoleic acid, ?-linolenic acid, or arachidonic acid (ARA) and/or derivatives thereof for use to increase the formation of one or more specialized pro-resolving lipid mediators (SPM) by gastrointestinal microorganisms in the gastrointestinal tract of humans or animals wherein the polyunsaturated fatty acid component comprises an omega-3 or omega-6 fatty acid salt.

Abstract: The invention relates to preparation comprising at least one probiotic strain belonging to the genus Bacillus megaterium, and a polyunsaturated fatty acid component comprising at least one omega-3 or omega-6 fatty acid selected from eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (ARA), alpha linolenic acid, stearidonic acid, eicosatetraenoic acid, docosapentaenoic acid, linoleic acid, ?-linolenic acid, wherein the polyunsaturated fatty acid component comprises an omega-3 or omega-6 fatty acid salt. The invention further relates to use of the inventive preparation as a feed or food supplement, pharmaceutical product, feed-or foodstuff compositions and for topical applications.

Abstract: The current invention concerns a new B. subtilis strain with strong inhibition of C. perfringens and its use as a probiotic.

Abstract: The current invention concerns a new B. licheniformis strain with strong inhibition of C. perfringens and its use as probiotic.

Abstract: The present invention pertains to an in vitro method for monitoring the load of at least one pathogen in an avian population, the method comprising the following steps: collecting and pooling excremental sample material deriving from an avian population; homogenizing the pooled sample material obtained in step (a); diluting and optionally stabilizing the pooled sample material obtained in step (b) with aqueous buffer solution; lysing the cell material contained in the diluted sample material obtained in step (c); isolating nucleic acid material from the lysed sample material of step (d); detecting and quantifying at least one pathogen-specific target gene, or functional fragment thereof, contained in the nucleic acid isolate obtained in step (e); repeating steps (a) to (f) at consecutive points in time; and observing alterations in amount of the at least one pathogen specific target gene over time.

Abstract: The present invention relates to a method for detecting C. perfringens induced diseases in animals, the method comprising: a) collecting sample material of a specific animal or of a specific group of animals at consecutive points in time; b) determining the amount of a first marker and a second marker contained in the sample material; and c) determining the ratio of the first marker to the second marker contained in the sample material; wherein the first marker comprises a polynucleotide sequence being specific for the C. perfringens sub-species inducing the targeted disease; and the second marker comprises a polynucleotide being specific for the species C. perfringens; and wherein an increase in the ratio of the first marker to the second marker in the analyzed sample material over time is an indication of the targeted disease.

Abstract: The present invention pertains to an in vitro method for detecting intestinal barrier failure in animals, the method comprising the following steps: a) collecting intestinal sample material of an individual animal or of an animal population; and b) determining the amount of at least one protein marker contained in said sample material; wherein the at least one protein marker comprises or consists of ovotransferrin or a functional fragment thereof, and wherein an increased amount of said at least one protein marker contained in said sample versus a reference sample indicates intestinal barrier failure.

Abstract: The present invention pertains to an in vitro method for detecting intestinal barrier failure in an avian population, the method comprising the following steps: a) collecting a pooled fecal sample deriving from an avian population and b) determining the amount of at least one protein marker contained in said sample; wherein the at least one protein marker comprises or consists of an acute phase protein or a functional fragment thereof, and wherein an increased amount of said at least one protein marker contained in said sample versus a reference sample indicates intestinal barrier failure.

Abstract: The present invention relates to an in vitro method for guiding measures against the propagation of Salmonella and/or against the propagation Campylobacter in an animal flock, the method comprising i.) determining the amount of at least one marker gene being specific for Salmonella or Campylobacter in a test sample and ii.) comparing the amount of said at least one marker gene being specific for Salmonella or Campylobacter determined in the test sample with a control sample, wherein an increase in the amount of said at least one marker gene being specific for Salmonella or Campylobacter in the test sample vs. the control sample by at least a factor of two, indicates the necessity of initiating or enhancing measures against the propagation of Salmonella and/or against the propagation Campylobacter.

Abstract: The current invention concerns a new B. subtilis strain with strong inhibition of swine and poultry related pathogens and its use as probiotic.

Abstract: The invention relates to a sheet-like composite including as layers of a layer sequence, in a direction from an external side of the sheet-like composite to an internal side of the sheet-like composite, a) a carrier layer, b) a barrier layer, and c) a polymeric internal layer, where a graph of a differential scanning calorimetry of the polymeric internal layer includes a peak A at a temperature TA and a peak B at a temperature TB, where the temperature TB is more than the temperature TA, where a width of the peak B is less by at least 3° C. than a width of the peak A. The invention further relates to a container precursor and to a closed container including the sheet-like composite, and also to a process by which the sheet-like composite is obtainable, and to a use of the sheet-like composite.

Abstract: The invention relates to a sheet-like composite including as layers of a layer sequence, in a direction from an external side of the sheet-like composite to an internal side of the sheet-like composite, a) a carrier layer, b) a polymeric intermediate layer, and c) a barrier layer, where a graph of differential scanning calorimetry of the polymeric intermediate layer includes a peak A at a temperature TA and a peak B at a temperature TB, where the temperature TB is more than the temperature TA, where a width of the peak B is less by at least 3° C. than a width of the peak A. The invention further relates to a container precursor and to a closed container including the sheet-like composite, and also to a process by which the sheet-like composite is obtainable, and to a use of the sheet-like composite.

Abstract: The current invention relates to a microvesicle based method of detecting avian necrotic enteritis as well as to new markers which have been identified as suitable for detection of avian necrotic enteritis and/or avian infection by Clostridium perfringens.

Abstract: The present invention generally relates to a sheetlike composite (3) comprising a layer configuration with the following layers: 0. optionally a layer of thermoplastic KSu (13); 1. a carrier layer (4); ii. a first layer of thermoplastic KSv (35); iii. a barrier layer (5); iv. a second layer of thermoplastic KSa (6); v. at least one further layer of thermoplastic KSw (7); wherein the Vicat softening temperature of the layer of thermoplastic KSv (35) and the Vicat softening temperature of the layer of thermoplastic KSa (6) is in each case higher than the Vicat softening temperature of the layer of thermoplastic KSw (7). The present invention furthermore relates to a process for the production of the sheetlike composite, a container which surrounds an interior and comprises at least one such sheetlike composite, and a process for the production of this container.

Abstract: The current invention concerns a new B. subtilis strain with strong inhibition of C. perfringens and its use as a probiotic.

Abstract: A planar composite for the production of a container surrounding an interior having a. a carrier layer; b. a barrier layer of plastic joined to the carrier layer; c. at least two layers of thermoplastic plastic which are provided on the side of the barrier layer of plastic facing away from the carrier layer. The carrier layer has at least one hole which is covered by the barrier layer of plastic and the at least two layers of thermoplastic plastic. The composite is useful for the production of a container. Also disclosed is a process for the production of a container using the composite and a container obtainable by this process.

Abstract: The present invention generally relates to a sheetlike composite (3) comprising a layer configuration with the following layers: 0. optionally a layer of thermoplastic KSu (13); 1. a carrier layer (4); ii. a first layer of thermoplastic KSv (35); iii. a barrier layer (5); iv. a second layer of thermoplastic KSa (6); v. at least one further layer of thermoplastic KSw (7); wherein the Vicat softening temperature of the layer of thermoplastic KSv (35) and the Vicat softening temperature of the layer of thermoplastic KSa (6) is in each case higher than the Vicat softening temperature of the layer of thermoplastic KSw (7). The present invention furthermore relates to a process for the production of the sheetlike composite, a container which surrounds an interior and comprises at least one such sheetlike composite, and a process for the production of this container.

Abstract: The invention relates to the biotechnological production of isomaltulose and isomaltulose-containing compositions and improved means, therefore particularly microbial cells.

Abstract: For the biotechnological production of isomaltulose and compositions containing isomaltulose from saccharose the invention provides improved means, particularly a sucrose mutase with improved product specificity as well as microbial cells containing the improved sucrose mutase.

Abstract: The present invention relates generally to a process for the production of a container surrounding an interior, comprising the steps a. provision of a planar composite comprising i. a carrier layer, ii. a barrier layer of plastic joined to the carrier layer, iii. at least two layers of thermoplastic plastic KSa and KSw which are provided on the side of the barrier layer of plastic facing away from the carrier layer, at least one of the at least two layers of plastic being a plastics mixture of at least two plastics, b. folding of the planar composite to form a fold with at least two fold surfaces adjacent to one another and c. joining of respectively at least a part region of the at least two fold surfaces by heating the part region to form a container region, at least one of the at least two layers of thermoplastic plastic in step b. having a temperature which is below the melting temperature of this layer of plastic, and a container obtainable by this process.